Therapeutic (Non-Preventive) Indications for Aspirin in Patients Over 60 Years
Aspirin 75-162 mg daily is strongly indicated for secondary prevention in patients over 60 with established atherosclerotic cardiovascular disease, including history of myocardial infarction, stroke/TIA, peripheral vascular disease, coronary revascularization, or angina. 1, 2
Secondary Prevention (Therapeutic Use)
The evidence overwhelmingly supports aspirin use in patients over 60 who have documented cardiovascular disease:
Clear Indications for Aspirin Therapy:
- History of myocardial infarction - Use 75-162 mg daily indefinitely 1, 2
- Prior ischemic stroke or transient ischemic attack - Use 75-162 mg daily 1, 3
- Established peripheral vascular disease or claudication - Use 75-162 mg daily 1
- History of coronary revascularization (bypass surgery or angioplasty) - Use 75-162 mg daily 1
- Stable or unstable angina pectoris - Use 75-162 mg daily 1
For acute coronary syndrome patients, dual antiplatelet therapy (aspirin plus a P2Y12 inhibitor like clopidogrel, ticagrelor, or prasugrel) is indicated for at least 1 year and may have benefits beyond this period. 2
Atrial Fibrillation Management
In patients over 60 with atrial fibrillation, aspirin has a limited but specific role:
- Aspirin 75-100 mg daily is an alternative in low-risk AF patients or those with contraindications to oral anticoagulation 4
- For patients undergoing cardioversion of AF lasting >2 days, anticoagulation (not aspirin alone) is the standard approach 4
- Aspirin may be optional for primary prevention in patients under 60 with lone AF, but this does not apply to your population over 60 4
Diabetes-Specific Considerations
For diabetic patients over 60 with established cardiovascular disease:
- Aspirin 75-162 mg daily is strongly recommended as secondary prevention 1, 2
- The benefit clearly outweighs bleeding risk in this population when used for secondary prevention 2
Alternative Agents
For patients with documented aspirin allergy, clopidogrel 75 mg daily should be used as an alternative. 2
Absolute Contraindications
Do not use aspirin in patients with: 1, 5
- Aspirin allergy or history of severe allergic reaction
- Active bleeding tendency or anticoagulant therapy requiring careful evaluation
- Recent gastrointestinal bleeding
- Clinically active hepatic disease
- Age under 21 years (Reye's syndrome risk)
Dosing Specifics
The optimal dose is 75-162 mg daily (81 mg is the most common U.S. formulation). 2 Lower doses (75 mg) are equally effective as higher doses (160-325 mg) and may have lower bleeding risk 1. There is no evidence that enteric-coated preparations reduce major GI bleeding compared to plain aspirin 6.
Critical Distinction: Primary vs. Secondary Prevention
This answer focuses on therapeutic/secondary prevention because for primary prevention in patients over 60-70 years, the balance has shifted toward greater risk than benefit 2. The 2019 ADA guidelines specifically note that for patients over 70 years, aspirin for primary prevention is generally not recommended due to increased bleeding risk outweighing cardiovascular benefits 2.
Bleeding Risk Management
For patients over 60 on aspirin for secondary prevention who are at increased GI bleeding risk (history of ulcer, concurrent NSAID use, age ≥60 with risk factors), consider co-prescribing a proton pump inhibitor 6. The bleeding risk increases with age, but in secondary prevention, the absolute cardiovascular benefit still substantially outweighs this risk 6.